Shandong Weigao Group Medical Polymer Co (UK2) Stock Forecast & Price Target
1 Followers
UK2 Analyst Ratings
Moderate Buy
4Buy2Hold0Sell
Based on 6 analysts giving stock ratings to Shandong Weigao Group Medical Polymer Co in the past 3 months
UK2 Stock 12 Month Forecast
Average Price Target
EUR 0.52▲(50.03% Upside)Based on 6 Wall Street analysts offering 12 month price targets for Shandong Weigao Group Medical Polymer Co in the last 3 months. The average price target is EUR 0.52 with a high forecast of EUR 0.58 and a low forecast of EUR 0.44. The average price target represents a 50.03% change from the last price of EUR 0.34.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 0.58
AverageEUR 0.52
LowEUR 0.44
Highest Price TargetHighestEUR 0.58Average Price TargetEUR 0.52Lowest Price TargetLowestEUR 0.44
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Zhongtai Securities | EUR 0.47 | buy | 37.29%Upside | Reiterated | 09/05/26 | ||
| Unknown AnalystNot Ranked | CICC | EUR 0.58 | buy | 68.72%Upside | Reiterated | 08/31/26 | ||
| Unknown AnalystNot Ranked | Citi | EUR 0.68→EUR 0.55 | buy | 58.79%Upside | Reiterated | 08/27/26 | ||
| Chris Pan | Goldman Sachs | EUR 0.44 | hold | 27.70%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | UBS | EUR 0.55 | buy | 58.79%Upside | Reiterated | 08/25/26 | ||
| Unknown AnalystNot Ranked | Morgan Stanley | EUR 0.51 | hold | 48.87%Upside | Reiterated | 08/25/26 | ||
| David Shang | Jefferies | EUR 0.63 | buy | 81.95%Upside | Reiterated | 03/30/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | EUR 0.85 | buy | 148.11%Upside | Reiterated | 03/23/26 | ||
| Unknown AnalystNot Ranked | Guotai Haitong | EUR 0.80 | buy | 131.57%Upside | Reiterated | 01/18/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Unknown AnalystZhongtai SecuritiesNot Ranked | BuyReiteratedEUR 0.47 | 09/05/26 | 37.29%Upside | ||
| Unknown AnalystCICCNot Ranked | BuyReiteratedEUR 0.58 | 08/31/26 | 68.72%Upside | ||
| Unknown AnalystCitiNot Ranked | BuyReiteratedEUR 0.68→EUR 0.55 | 08/27/26 | 58.79%Upside | ||
| Chris PanGoldman Sachs | HoldReiteratedEUR 0.44 | 08/26/26 | 27.70%Upside | ||
| Unknown AnalystUBSNot Ranked | BuyReiteratedEUR 0.55 | 08/25/26 | 58.79%Upside | ||
| Unknown AnalystMorgan StanleyNot Ranked | HoldReiteratedEUR 0.51 | 08/25/26 | 48.87%Upside | ||
| David ShangJefferies | BuyReiteratedEUR 0.63 | 03/30/26 | 81.95%Upside | ||
| Unknown AnalystCitic SecuritiesNot Ranked | BuyReiteratedEUR 0.85 | 03/23/26 | 148.11%Upside | ||
| Unknown AnalystGuotai HaitongNot Ranked | BuyReiteratedEUR 0.80 | 01/18/26 | 131.57%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Shandong Weigao Group Medical Polymer Co
3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
+6.35%
Copying David Shang's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.35% per trade.
1 Year
Success Rate1/2 ratings generated profit
50%
Average Return
+6.10%
Copying David Shang's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +6.10% per trade.
2 Years
Success Rate1/2 ratings generated profit
50%
Average Return
-10.50%
Copying PerPlexity Medical - Instruments and Supplies's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -10.50% per trade.
UK2 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 |
| Buy | 0 | 2 | 3 | 3 | 1 |
| Hold | 0 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 6 | 7 | 6 | 1 |
In the current month, UK2 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. UK2 average Analyst price target in the past 3 months is 0.52.
UK2 Financial Forecast
HighEUR 0.02
ConsensusEUR 0.02
LowEUR 0.02
UK2 Earnings Forecast
Next quarter’s earnings estimate for UK2 is EUR 0.02 with a range of EUR 0.02 to EUR 0.02. The previous quarter’s EPS was EUR 0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 914M
ConsensusEUR 914M
LowEUR 914M
UK2 Sales Forecast
Next quarter’s sales forecast for UK2 is EUR 914.47M with a range of EUR 914.47M to EUR 914.47M. The previous quarter’s sales results were EUR 873.90M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
UK2 Stock Forecast FAQ
What is DE:UK2’s average 12-month price target, according to analysts?
Based on analyst ratings, Shandong Weigao Group Medical Polymer Co’s 12-month average price target is €0.52.
What is DE:UK2’s upside potential, based on the analysts’ average price target?
Shandong Weigao Group Medical Polymer Co has 50.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Shandong Weigao Group Medical Polymer Co a Buy, Sell or Hold?
Shandong Weigao Group Medical Polymer Co has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
What is Shandong Weigao Group Medical Polymer Co’s share price target?
The average share price target for Shandong Weigao Group Medical Polymer Co is €0.52. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €0.58, and the lowest forecast is €0.44. The average share price target represents a 50.03% increase from the current price of €0.344.
What do analysts say about Shandong Weigao Group Medical Polymer Co?
Shandong Weigao Group Medical Polymer Co’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of Shandong Weigao Group Medical Polymer Co?
To buy shares of DE:UK2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
